For the quarter ending 2025-09-30, ORIC has $431,192K in assets. $24,273K in debts. $49,668K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 49,668 | 75,864 | ||
| Short-term investments | 237,472 | 206,649 | ||
| Prepaid expenses and other current assets | 8,454 | 8,611 | ||
| Total current assets | 295,594 | 291,124 | ||
| Long-term investments | 125,908 | 45,216 | ||
| Total property and equipment, gross | 10,720 | - | ||
| Less accumulated depreciation | 8,161 | - | ||
| Property and equipment, net | 2,559 | 2,762 | ||
| Other assets | 7,131 | 7,755 | ||
| Total assets | 431,192 | 346,857 | ||
| Accounts payable | 2,900 | 3,130 | ||
| Accrued liabilities | 17,279 | 14,920 | ||
| Total current liabilities | 20,179 | 18,050 | ||
| Other long-term liabilities | 4,094 | 4,812 | ||
| Total liabilities | 24,273 | 22,862 | ||
| Common stock, 0.0001 par value 1,000,000,000 shares authorized 97,278,032 and 71,021,855 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 11 | 9 | ||
| Additional paid-in capital | 1,068,030 | 952,949 | ||
| Accumulated deficit | -661,737 | -629,150 | ||
| Accumulated other comprehensive income | 615 | 187 | ||
| Total stockholders' equity | 406,919 | 323,995 | ||
| Total liabilities and stockholders' equity | 431,192 | 346,857 | ||
Oric Pharmaceuticals, Inc. (ORIC)
Oric Pharmaceuticals, Inc. (ORIC)